Medicine/Health | EUROPEAN FRIENDS OF THE HEBREW UNIVERSITY

New Study Finds Financial Strain of Cancer Treatment Undermines Hope and Life Satisfaction

26 February, 2026

Cancer treatment can take a profound financial toll, and new research shows the damage does not stop at the bank account. Nearly half of patients experience significant “financial toxicity,” and that strain quietly chips away at hope and social support, two pillars that sustain people through illness. As those erode, overall satisfaction with life declines. The findings suggest that addressing the cost of care is not only a financial issue but a psychological one, and that protecting patients’ hope and sense of connection may be just as critical as covering their bills.

Hebrew University Establishes Sally Einstein Brain Research Program to Tackle the Infectious Roots of Neurodegenerative Disease

18 February, 2026

The Hebrew University of Jerusalem is proud to announce the establishment of the Sally Einstein Brain Research Program, made possible by a 1 Million NIS grant (USD $300,930) from the Sim Einstein Research Foundation, Inc.

Malaria: Newly Identified “Crown” Stage Controls Parasite Reproduction

5 February, 2026

Cancer’s Super-Enhancers May Set the Map for DNA Breaks and Repair: A Key Clue to Why Tumors Become Aggressive and Genetically Unstable

21 January, 2026

Hebrew University-Hadassah School of Dental Medicine Establishes the Robert I. Schattner Oral Health Center for People with Disabilities

15 December, 2025

JERUSALEM, December 15, 2025 – The Hebrew University-Hadassah School of Dental Medicine is proud to announce the establishment of the Robert I. Schattner Center for Oral Health for People with Disabilities, an innovative center dedicated to providing quality dental care for people with physical, cognitive, and complex medical conditions.

Hebrew University Launches Pioneering Academic Center for Addiction and Mental Health

25 November, 2025

The Hebrew University of Jerusalem has officially launched the Israel Center for Addiction and Mental Health (ICAMH), a landmark initiative established in response to the escalating mental-health and addiction crisis in Israel and around the world. Founded in collaboration with the Israel Center on Addiction (ICA), the centre aims to become a leading hub for research, innovation and treatment in this critical field.

New Study Reveals How Immune Cells Help Defend Against Candida Infections

27 October, 2025

New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida infections by using the CD48 receptor to recognize the fungus and release proteins that stop its growth. This discovery is important because it reshapes how we understand the immune system and opens the door to new therapies that could strengthen natural defenses against life-threatening fungal infections, a growing challenge in hospitals worldwide.

New Way to Destroy a Cancer-Linked Molecule Revealed

22 October, 2025

Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.

Study Finds Protein Target That Predicts Drug Resistance in Colon Cancer

20 October, 2025

New Hope for Cats with Eye Infections: Study Finds Common Cold Sore Cream Safe and Effective for Feline Use

20 October, 2025

A common human cold sore cream may soon help cats with painful eye infections: researchers found that 1% penciclovir cream (Fenlips®), when applied to cats’ eyes, was safe, well-tolerated, and maintained antiviral levels for over eight hours—suggesting that twice-daily use could effectively manage feline herpesvirus type 1, a leading cause of eye disease in cats.